Skip to Content

AptarGroup Inc ATR

Morningstar Rating
$146.85 +1.04 (0.71%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Aptar's Profitability Improving Due to Pharma Growth and Cost Controls

Aptar is a global leader in dispensing technologies and operates under three business segments, Aptar Pharma, Aptar Beauty, and Aptar Closures. The company specializes in various drug dispensing solutions including nasal spray inhalers and elastomer components for injectable drugs, high-end fragrance pumps, and food dispensing closures. While Aptar’s portfolio includes lower-margin products such as shampoo and soap pumps and caps for sauce bottles, it has intentionally focused on growing the higher-margin healthcare business over the past decade, which now accounts for about two thirds of operating profits.

Price vs Fair Value

ATR is trading within a range we consider fairly valued.
Price
$146.85
Fair Value
$718.00
Uncertainty
Medium
1-Star Price
$388.44
5-Star Price
$751.70
Economic Moat
Mzbrky
Capital Allocation
Shfxbrg

Bulls Say, Bears Say

Bulls

Aptar’s strong relationships with multinational customers will help the firm expand into emerging markets such as Asia and Latin America.

Bears

Aptar’s negotiating power could decline along with further consolidation of large consumer and pharmaceutical companies.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ATR is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$145.81
Day Range
$145.31147.14
52-Week Range
$111.63151.73
Bid/Ask
$141.33 / $149.28
Market Cap
$9.73 Bil
Volume/Avg
444,074 / 289,256

Key Statistics

Price/Earnings (Normalized)
28.85
Price/Sales
2.78
Dividend Yield (Trailing)
1.12%
Dividend Yield (Forward)
1.12%
Total Yield
1.53%

Company Profile

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (50% of sales) and the United States (33%), Aptar aims to increase its presence in Asia (10%) and Latin America (7%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Mid Core
Total Number of Employees
13,800

Competitors

Valuation

Metric
ATR
PODD
WST
Price/Earnings (Normalized)
28.8563.3941.49
Price/Book Value
4.1418.079.06
Price/Sales
2.788.548.52
Price/Cash Flow
16.3841.3932.61
Price/Earnings
ATR
PODD
WST

Financial Strength

Metric
ATR
PODD
WST
Quick Ratio
0.772.481.74
Current Ratio
1.303.742.61
Interest Coverage
10.896.8876.96
Quick Ratio
ATR
PODD
WST

Profitability

Metric
ATR
PODD
WST
Return on Assets (Normalized)
8.50%7.81%15.47%
Return on Equity (Normalized)
16.67%30.26%20.59%
Return on Invested Capital (Normalized)
11.51%9.66%17.98%
Return on Assets
ATR
PODD
WST
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
CdbnrlzwXmg$153.4 Bil
Becton Dickinson & Co
BDX
VtwzkjjrZqfww$68.9 Bil
Alcon Inc
ALC
RlffwlpjJrqxts$43.9 Bil
ResMed Inc
RMD
HvwvzynnkWrdvhch$30.2 Bil
Coloplast A/S ADR
CLPBY
WlrdpscwlCbvfm$27.3 Bil
West Pharmaceutical Services Inc
WST
HwvyzdxgfYhvw$24.4 Bil
The Cooper Companies Inc
COO
VzdqtlkkTwgtsl$18.2 Bil
Baxter International Inc
BAX
CprqpvlySzhcbvl$17.5 Bil
Hologic Inc
HOLX
JyhjzymdjLlkqchh$17.1 Bil

Sponsor Center